浏览全部资源
扫码关注微信
秦皇岛市第一医院药学部,河北 秦皇岛 066000
主管药师,硕士。研究方向:临床药学。电话:0335-5908439。E-mail:yuxiaojie213@163.com
主任药师,博士。研究方向:医院药学。电话:0335-5908456。E-mail:wangncqhd@163.com
纸质出版日期:2024-01-15,
收稿日期:2023-06-21,
修回日期:2023-09-11,
扫 描 看 全 文
于小杰,杨文明,宋萍萍等.碳青霉烯类耐药肺炎克雷伯菌致血流感染风险预测模型的构建 Δ[J].中国药房,2024,35(01):75-79.
YU Xiaojie,YANG Wenming,SONG Pingping,et al.Construction of a risk prediction model for bloodstream infection induced by carbapenem-resistant Klebsiella pneumoniae[J].ZHONGGUO YAOFANG,2024,35(01):75-79.
于小杰,杨文明,宋萍萍等.碳青霉烯类耐药肺炎克雷伯菌致血流感染风险预测模型的构建 Δ[J].中国药房,2024,35(01):75-79. DOI: 10.6039/j.issn.1001-0408.2024.01.13.
YU Xiaojie,YANG Wenming,SONG Pingping,et al.Construction of a risk prediction model for bloodstream infection induced by carbapenem-resistant Klebsiella pneumoniae[J].ZHONGGUO YAOFANG,2024,35(01):75-79. DOI: 10.6039/j.issn.1001-0408.2024.01.13.
目的
2
构建碳青霉烯类耐药肺炎克雷伯菌(CRKP)致血流感染(BSI)风险预测模型。
方法
2
回顾性分析秦皇岛市第一医院2019年1月-2022年6月253例肺炎克雷伯菌致BSI患者的临床资料,将2019年1月-2021年12月收治的患者(223例)作为模型组,2022年1-6月收治的患者(30例)作为验证组。根据是否检出CRKP将模型组患者分为CRKP亚组(56例)和碳青霉烯类敏感肺炎克雷伯菌(CSKP)亚组(167例),对两亚组患者性别、年龄、合并基础疾病等基本信息进行单因素分析和多因素Logistic分析,筛选CRKP致BSI的独立危险因素并构建风险预测模型;以验证组患者为对象,对所建模型进行验证。
结果
2
患者入住重症监护病房(ICU)、使用免疫抑制剂和经验性抗感染治疗中使用碳青霉烯类抗菌药物、抗革兰氏阳性球菌药物是CRKP致BSI的独立危险因素(比值比分别为3.749、3.074、2.909、9.419,95%置信区间分别为1.639~8.572、1.292~7.312、1.180~7.717、2.877~30.840,
P
<0.05);所建风险预测模型的
P
值为0.365,模型受试者工作特征曲线的曲线下面积(AUC)为0.848(95%置信区间为0.779~0.916,
P
<0.001),分值临界值为6.5。用于验证组患者时,模型预测的总体准确率为86.67%,其生存曲线的AUC为0.926(95%置信区间为0.809~1.000,
P
<0.001)。
结论
2
患者入住ICU、使用免疫抑制剂和经验性抗感染治疗中使用碳青霉烯类抗菌药物、抗革兰氏阳性球菌药物是CRKP致BSI的独立危险因素;基于上述因素所建的CRKP致BSI风险预测模型的预测准确性良好。
OBJECTIVE
2
To construct a risk prediction model for bloodstream infection (BSI) induced by carbapenem-resistant
Klebsiella pneumoniae
(CRKP).
METHODS
2
Retrospective analysis was conducted for clinical data from 253 patients with BSI induced by
K. pneumoniae
in the First Hospital of Qinhuangdao from January 2019 to June 2022. Patients admitted from January 2019 to December 2021 were selected as the model group (
n
=223), and patients admitted from January 2022 to June 2022 were selected as the validation group (
n
=30). The model group was divided into the CRKP subgroup (
n
=56) and the carbapenem-sensitive
K. pneumoniae
(CSKP) subgroup (
n
=167) based on whether CRKP was detected or not. The univariate and multivariate Logistic analyses were performed on basic information such as gender, age and comorbid underlying diseases in two subgroups of patients; independent risk factors were screened for CRKP-induced BSI, and a risk prediction model was constructed. The established model was verified with patients in the validation group as the target.
RESULTS
2
Admissioning to intensive care unit (ICU), use of immunosuppressants, empirical use of carbapenems and empirical use of antibiotics against Gram-positive coccus were independent risk factors of CRKP-induced BSI (ORs were 3.749, 3.074, 2.909, 9.419, 95%CIs were 1.639-8.572, 1.292-7.312, 1.180-7.717, 2.877-30.840,
P
<0.05). Based on this, a risk prediction model was established with a
P
value of 0.365. The AUC of the receiver operating characteristic (ROC) curve of the model was 0.848 [95%CI (0.779, 0.916),
P
<0.001], and the critical score was 6.5. In the validation group, the overall accuracy of the prediction under the model was 86.67%, and the AUC of ROC curve was 0.926 [95%CI (0.809, 1.000]
,
P
<0.001].
CONCLUSIONS
2
Admission to ICU, use of immunosuppressants, empirical use of carbapenems and empirical use of antibiotics against Gram-positive coccus are independent risk factors of CRKP-induced BSI. The CRKP-induced BSI risk prediction model based on the above factors has good prediction accuracy.
碳青霉烯类耐药肺炎克雷伯菌血流感染危险因素风险预测模型
bloodstream infectionrisk factorsrisk prediction model
吴风,胡锡池,胡仁静. 感染碳青霉烯类耐药肺炎克雷伯菌患者全因死亡Meta分析[J]. 检验医学与临床,2017,14(2):217-221.
WU F,HU X C,HU R J. All-cause deaths attributable to carbapenem-resistant Klebsiella pneumoniae infection:meta analysis[J]. Lab Med Clin,2017,14(2):217-221.
HU F P,CHEN S D,XU X G,et al. Emergence of carbapenem-resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai,China[J]. J Med Microbiol,2012,61(Pt 1):132-136.
于小杰,杨文明,宋萍萍,等. 肺炎克雷伯菌血流感染预后分析及死亡风险预测模型的构建[J]. 中华临床感染病杂志,2023,16(2):128-133.
YU X J,YANG W M,SONG P P,et al. Risk factors of mortality in Klebsiella pneumoniae bloodstream infection and construction of a prediction model for prognosis of patients[J]. Chin J Clin Infect Dis,2023,16(2):128-133.
尹章勇,周华,符一骐,等. 耐碳青霉烯类肺炎克雷伯菌血流感染的临床特征和死亡危险因素分析[J]. 中国感染与化疗杂志,2020,20(4):388-395.
YIN Z Y,ZHOU H,FU Y Q,et al. Clinical manifestations and risk factors for mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infections[J]. Chin J Infect Chemother,2020,20(4):388-395.
曹培,杨勇,张志勇. 耐碳青霉烯类肺炎克雷伯菌血流感染患者死亡危险因素分析[J]. 医药导报,2021,40(8):1048-1052.
CAO P,YANG Y,ZHANG Z Y. Analysis of mortality-related factors in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infections[J]. Her Med,2021,40(8):1048-1052.
卫生部. 医院感染诊断标准:试行[J]. 中华医学杂志,2001,81(5):314-320.
Ministry of Health. Diagnostic criteria for nosocomial infection:for trial implementation[J]. Natl Med J China,2001,81(5):314-320.
卫生部医政司. 全国临床检验操作规程:第3版[M]. 南京:东南大学出版社,2006:2350.
Medical Affairs Department of the Ministry of Health. National guide to clinical laboratory procedures:third edition[M]. Nanjing:Southeast University Press,2006:2350.
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing,29th edition[M]. Wayne:CLSI,2019:1-93.
代强,郑波. 2012美国疾病预防控制中心耐碳青霉烯类肠杆菌控制指南简介[J]. 中国医学前沿杂志(电子版),2013,5(8):74-75[2023-05-30]. https://kns.cnki.net/kcm-s2/article/abstract?v=jeDOxXNM7l5DrPPRSu2BdaeuLISS-https://kns.cnki.net/kcm-s2/article/abstract?v=jeDOxXNM7l5DrPPRSu2BdaeuLISS-
ygvrw6_HzF5ugCQO6w7PNVxEQT_ezoaiIC4Ugk5llHCQ-s4kx_G79q38pa_wl-GHvqPWiCXKuiq9w3FrwTvabOu-j2TbPshcO6-ckGlgPzON9Wio=&uniplatform=NZKPT&language=CHS. DOI:10.3969/j.issn.1674-7372.2013.08.007http://dx.doi.org/10.3969/j.issn.1674-7372.2013.08.007.
DAI Q,ZHENG B. Introduction of 2012 US Centers for Disease Control and Prevention Control guidelines for carbapenem-resistant Enterobacteriaceae[J/OL]. Chin J Front Med Sci Electron Version,2013,5(8):74-75[2023-05-30]. https://kns.cnki.net/kcms2/article/abstract?v= jeDOxXNM7l5DrPPRSu2BdaeuLISSygvrw6_HzF5ug-CQO6w7PNVxEQT_ezoaiIC4Ugk5llHCQs4kx_G79q38pa_ wl-GHvqPWiCXKuiq9w3FrwTvabOuj2TbPshcO6-ckGlgPzON9Wio=&uniplatform=NZKPT&language=CHS. DOI: 10.3969/j.issn.1674-7372.2013.08.007https://kns.cnki.net/kcms2/article/abstract?v=jeDOxXNM7l5DrPPRSu2BdaeuLISSygvrw6_HzF5ug-CQO6w7PNVxEQT_ezoaiIC4Ugk5llHCQs4kx_G79q38pa_wl-GHvqPWiCXKuiq9w3FrwTvabOuj2TbPshcO6-ckGlgPzON9Wio=&uniplatform=NZKPT&language=CHS.DOI:10.3969/j.issn.1674-7372.2013.08.007.
黄丽萍,林嘉萍,余雪莹,等. 114例成人肺炎克雷伯菌血流感染的临床特征及预后[J]. 中国感染与化疗杂志,2022,22(6):680-687.
HUANG L P,LIN J P,YU X Y,et al. Clinical characteristics and outcomes of 114 bloodstream infections caused by Klebsiella pneumoniae in adult patients[J]. Chin J Infect Chemother,2022,22(6):680-687.
刘一瑾. 血流感染金黄色葡萄球菌的耐药性、甲氧西林耐药株感染风险预测模型的初步建立及评价[D]. 石家庄:河北医科大学,2021.
LIU Y J. Drug resistance of Staphylococcus aureus in bloodstream infection,preliminary establishment and evaluation of risk prediction model for infection of methicillin-resistant strains[D]. Shijiazhuang:Hebei Me-dical University,2021.
宋子璇,刘卫平. 基于人工神经网络及Logistic回归的耐碳青霉烯类革兰阴性菌感染预测模型研究[J]. 中国消毒学杂志,2023,40(4):276-279.
SONG Z X,LIU W P. Prediction model of carbapenem-resistant Gram-negative bacteria infection based on artificial neural network and Logistic regression[J]. Chin J Disinfect,2023,40(4):276-279.
SEVERIN A,TABEI K,TENOVER F,et al. High level oxacillin and vancomycin resistance and altered cell wall composition in Staphylococcus aureus carrying the staphylococcal mecA and the enterococcal vanA gene complex[J]. J Biol Chem,2004,279(5):3398-3407.
胡付品,郭燕,朱德妹,等. 2020年CHINET中国细菌耐药监测[J]. 中国感染与化疗杂志,2021,21(4):377-387.
HU F P,GUO Y,ZHU D M,et al. CHINET surveillance of bacterial resistance:results of 2020[J]. Chin J Infect Chemother,2021,21(4):377-387.
XU L F,SUN X X,MA X L. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae[J]. Ann Clin Microbiol Antimicrob,2017,16(1):18.
王娜,张珍珍,刘一瑾,等. 医院血流感染革兰阴性菌分布及耐药性变迁[J]. 中华临床感染病杂志,2020,13(3):205-209.
WANG N,ZHANG Z Z,LIU Y J,et al. Trends of distribution and antimicrobial resistance profile of Gram-negative bacteria in hospital bloodstream infection[J]. Chin J Clin Infect Dis,2020,13(3):205-209.
王娜,阎彦,杨文明,等. 2012-2017年某院耐碳青霉烯肺炎克雷伯菌变迁及耐药性[J]. 中国抗生素杂志,2019,44(4):467-470.
WANG N,YAN Y,YANG W M,et al. The epidemiology and antibiotic resistance of carbapenem-resistant Kleb-siella pneumoniae in a hospital from 2012 to 2017[J]. Chin J Antibiot,2019,44(4):467-470.
李秋敬,王真,高倩,等. 肺炎克雷伯菌血流感染患者的临床特征及预后相关因素分析[J]. 中华全科医师杂志,2022,21(6):560-566.
LI Q J,WANG Z,GAO Q,et al. Clinical characteristics and prognostic factors of patients with Klebsiella pneumoniae bloodstream infection[J]. Chin J Gen Pract,2022,21(6):560-566.
陈燕,赵瑞红,涂盛,等. 耐碳青霉烯类肺炎克雷伯菌血流感染危险因素及预后分析[J]. 中国微生态学杂志,2019,31(12):1424-1430.
CHEN Y,ZHAO R H,TU S,et al. Analysis of risk factors and prognostic factors of bloodstream infection by carbapenem-resistant Klebsiella pneumoniae[J]. Chin J Microecol,2019,31(12):1424-1430.
LOU T,DU X X,ZHANG P,et al. Risk factors for infection and mortality caused by carbapenem-resistant Kleb-siella pneumoniae:a large multicentre case-control and cohort study[J]. J Infect,2022,84(5):637-647.
陈云波,嵇金如,应超群,等. 2018至2019年度全国血流感染细菌耐药监测报告[J]. 中华临床感染病杂志,2021,14(1):32-45.
CHEN Y B,JI J R,YING C Q,et al. BRICS report of 2018-2019:the distribution and antimicrobial resistance profile of clinical isolates from blood culture in China[J]. Chin J Clin Infect Dis,2021,14(1):32-45.
吴忻晶,屈芬芬,李婷,等. 耐碳青霉烯类肺炎克雷伯菌血流感染危险因素分析及列线图预测模型构建[J]. 传染病信息,2022,35(5):457-462.
WU X J,QU F F,LI T,et al. Analysis of risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection and construction of a nomogram prediction model[J]. Infect Dis Inf,2022,35(5):457-462.
0
浏览量
7
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构